NHS-Industry Partnership Programmes
When collaboration meets real world access challenges.
Breakthrough medicines only deliver value when patients can access them at scale.
Accession works alongside pharmaceutical partners to translate value and access strategies into real world adoption. Navigating NHS complexity, shaping access strategies, and supporting sustainable implementation through partnership working.
Partnerships that align innovation, evidence, and system priorities.
PATHWAYPRO®
Most pathway redesign decisions are made without a clear, end-to-end view of how patients actually move through the system.
pathwaypro® provides that visibility.
It shows the current disease level care pathway end-to-end, then uses discrete event simulation modelling to safely model new models of care before they are implemented by services.
This allows NHS system leaders to see the impact on patient flow, capacity, and waiting and to choose options based on modelled evidence, not assumption.
pathwaypro® reduces redesign risk by making pathway change visible, testable, and credible before patients and staff experience it.
EXEMPLAR PATHWAYS
An ongoing investment in drug development by the pharmaceutical industry means new and novel medicines are continuing to emerge. Whilst many of these innovative technologies are fulfilling areas of unmet need, in many instances the care pathway or service is not in place to support patient access. Accession works alongside industry clients and the NHS to design and develop exemplar pathways that allow the value of innovative medicines to be realised by healthcare systems.
TRANSFORMATION TOOLKIT™ DEVELOPING NEW MODELS OF CARE
Accession’s Transformation Toolkit™ uses enquiry-based investigations to develop a proposal for the transformation of services across end-to-end disease level pathways.
The Transformation Toolkit™ is made up of a number of separate components that drawn together provide an effective process to support clinicians and commissioners in developing new models of care. Supported and delivered by industry through partnership and joint working.
Let's Innovate!
If you have a problem, a barrier, or a seemingly insurmountable market access challenge talk to us, we can help. Let’s innovate!
Find out more or request a meeting...
